Form D · Biotechnology
Amend Surgical, Inc.
Gainesville, FL · CIK 0001656957
Offering snapshot reported Jun 25, 2024 · SEC filing
- Reported sold
- $1.05M Offering amount: $3.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2024 | Initial | $1,049,473 | No comparison | 5 | SEC filing |
| Apr 5, 2017 | Initial | $200,000 | No comparison | 3 | SEC filing |
| Apr 15, 2016 | Initial | $650,000 | No comparison | 4 | SEC filing |
| Dec 21, 2015 | Initial | $0 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516811
Source: Form D, filed Jun 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Ascani | Director |
| Ronald R. Cobb | Director |
| James F. Kirk | Director |
| Robert Lane | Director, Executive |
| Leslie Molony | Director |
| Jane Leslie Molony | Director |
| Michael Orrico | Director |
| Wade Pilling | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5134 Sw 106th Way
Gainesville, FL, 32608
Gainesville, FL, 32608